Health

Oxygen-filled nanobubbles combined with ultrasound can reduce levels of pathogenic bacteria including Vibrio parahaemolyticus and Aeromonas hydrophila in RAS, according to new research.

Bacteriophages can prove an effective alternative to the use of antibiotics to tackle Vibrio infections in shrimp aquaculture, according to a new study.

A new aquaculture vaccine development company has been launched by Touchlight Genetics and Stonehaven Incubate.

The European Food Safety Authority (EFSA) will re-evaluate its risk assessment of parasites in farmed fish after reviewing new research.

BMK08, a novel treatment against sea lice, is one step closer to commercial launch, having been recommended for approval by the EU’s Committee for Medicinal Products for Veterinary Use (CVMP).

Shellfish genetics and breeding company Pacific Hybreed is taking part in a NOAA-funded project to develop genetic markers for resistance to the virus causing Pacific oyster mortality syndrome (POMS).

Sea lice may be able to adapt in order to avoid a range of physical barriers that are designed to prevent them from reaching farmed salmon.

Marine Akwa is currently in the process of developing a range of probiotics – based on marine organisms – for the finfish aquaculture industry, in a bid to improve growth rates, survival levels and health benefits.

Combining the use of innovative technologies and lessons learned from the terrestrial livestock sector will enable huge improvements in the aquaculture indsutry, according to Laurent Genet, chief strategy officer at Nutr…

Mozambique’s fishery authorities say they are on high alert for a potential outbreak of red spot disease after a recent outbreak in neighbouring Malawi.

The governments of the five largest shrimp producing nations have been urged to take increased and immediate action to address the continued outbreak and emergence of new diseases in shrimp farms.

New methods for performing freshwater treatments against sea lice and amoebic gill disease (AGD) in salmon farms have been successfully developed and trialled in Ireland.

A recently developed on-farm detection kit for piscirickettsiosis (SRS) can confirm the bacteria’s presence within 90 minutes and might help reduce the impact of a disease that costs the Chilean salmon industry $750 mill…

A $29 million project to develop and commercialise world-class solutions for monitoring fish health, fish movement, and the environment – in a bid to make marine sectors, including aquaculture, more sustainable - has bee…

Benchmark is selling its vaccine manufacturing facility as part of a £100 million UK government project to mass produce a vaccine against Covid-19.

A new technology that is designed to kill Neoparamoeba perurans, the parasite which causes amoebic gill disease (AGD) in Atlantic salmon, has been successfully trialled in vitro.

Folium Science has developed a new partnership to extend the application of its “guided biotics” technology to farmed salmon.